Vive La France: Regulatory Approval Received
21 June 2016
ASX ANNOUNCEMENT
Vive La France: Regulatory Approval Received
Medical Developments International Limited (ASX: MVP) is delighted to announce it has received Marketing Authorisation for Penthrox in France for the emergency relief of moderate to severe pain in conscious adult patients with trauma and associated pain.
MVP CEO, Mr John Sharman, said: “This is an exciting achievement for MVP. With French approval we can begin to sell product in France and Belgium. Preparations for the launch of Penthrox in France and Belgium are well advanced.”
For details relating to the full ASX release please click on the following link French Regulatory Approval Received